急性腎不全(急性腎傷害)(Acute Renal Failure (ARF) (Acute Kidney Injury))：世界の治験レビュー（2015年上半期版）...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 6
Introduction 7
Acute Renal Failure (ARF) (Acute Kidney Injury) 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Acute Renal Failure (ARF) (Acute Kidney Injury) to Genito Urinary System And Sex Hormones Clinical Trials 16
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Acute Renal Failure (ARF) (Acute Kidney Injury) to Genito Urinary System And Sex Hormones Clinical Trials 19
Clinical Trials by Phase in E7 Countries 20
Clinical Trials in E7 Countries by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Clinical Trials by End Point Status 25
Unaccomplished Trials of Acute Renal Failure (ARF) (Acute Kidney Injury) 26
Subjects Recruited Over a Period of Time 30
Clinical Trials by Sponsor Type 31
Prominent Sponsors 32
Top Companies Participating in Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials 33
Prominent Drugs 34
Latest Clinical Trials News on Acute Renal Failure (ARF) (Acute Kidney Injury) 35
Jan 20, 2015: AM-Pharma starts Adaptive Phase II trial of recAP in Acute Kidney Injury 35
Dec 15, 2014: Complexa Initiates Phase 1B Study of CXA-10 in Acute Kidney Injury 35
Clinical Trial Profiles 36
Clinical Trial Overview of Top Companies 36
AbbVie Inc. 36
Clinical Trial Overview of AbbVie Inc. 36
Action Pharma A/S 37
Clinical Trial Overview of Action Pharma A/S 37
F. Hoffmann-La Roche Ltd. 38
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 38
AstraZeneca PLC 39
Clinical Trial Overview of AstraZeneca PLC 39
SBI Biotech Co., Ltd. 40
Clinical Trial Overview of SBI Biotech Co., Ltd. 40
GlaxoSmithKline plc 41
Clinical Trial Overview of GlaxoSmithKline plc 41
Complexa, Inc. 42
Clinical Trial Overview of Complexa, Inc. 42
NephroGenex, Inc. 43
Clinical Trial Overview of NephroGenex, Inc. 43
Am-Pharma B.V. 44
Clinical Trial Overview of Am-Pharma B.V. 44
AlloCure Inc. 45
Clinical Trial Overview of AlloCure Inc. 45
Clinical Trial Overview of Top Institutes / Government 46
Yonsei University 46
Clinical Trial Overview of Yonsei University 46
Austin Health 47
Clinical Trial Overview of Austin Health 47
Vanderbilt University 48
Clinical Trial Overview of Vanderbilt University 48
Medical University of Vienna 49
Clinical Trial Overview of Medical University of Vienna 49
University of Alberta 50
Clinical Trial Overview of University of Alberta 50
Seoul National University Hospital 51
Clinical Trial Overview of Seoul National University Hospital 51
Asan Medical Center 52
Clinical Trial Overview of Asan Medical Center 52
University of Florida 53
Clinical Trial Overview of University of Florida 53
Tehran University of Medical Sciences 54
Clinical Trial Overview of Tehran University of Medical Sciences 54
Ospedale Misericordia e Dolce 55
Clinical Trial Overview of Ospedale Misericordia e Dolce 55
Five Key Clinical Profiles 56
Appendix 97
Abbreviations 97
Definitions 97
Research Methodology 98
Secondary Research 98
About GlobalData 99
Contact Us 99
Disclaimer 99
Source 99